Izvorni znanstveni članak
QUALITY OF LIFE IN PEOPLE AFFECTED BY PSORIASIS IN RELATION TO THE SEVERITY OF CLINICAL FEATURES AND PRESENCE OF COMORBIDITY
NERMINA HADŽIGRAHIĆ
; Univerzitetsko-klinički centar Tuzla, Klinika za kožne bolesti, Tuzla, Bosna i Hercegovina
ELDINA MALKIĆ SALIHBEGOVIĆ
; Dom zdravlja Živinice, Živinice, Bosna i Hercegovina
NERMINA KURTALIĆ
; Kantonalna bolnica “Dr. Irfan Ljubijankić”, Odjel za dermatovenerologiju, Bihać, Bosna i Hercegovina
SADAT KURTALIĆ
; Kantonalna bolnica “Dr. Irfan Ljubijankić”, Odjel za dermatovenerologiju, Bihać, Bosna i Hercegovina
ESAD OMERKIĆ
; Dom zdravlja Živinice, Živinice, Bosna i Hercegovina
Sažetak
The quality of life in patients with psoriasis was examined in relation to the severity of clinical features and presence of comorbidity. This cross-sectional study analyzed the quality of life in 120 patients affected by psoriasis, age over 18, both genders, treated at Department of Dermatology, Tuzla University Clinical Center in Tuzla from November 1, 2014 to June 2016. Study subjects were divided into two groups according to the presence of comorbidity (metabolic syndrome, obesity,
hypertension, diabetes): group 1 consisted of 70 patients with comorbidity, while group 2 consisted of 50 patients without comorbidity. The Psoriasis Area and Severity Index (PASI) was used to evaluate the severity and spread of psoriasis. The quality of life in psoriasis patients was evaluated by use of the Skindex-29 questionnaire, which consists of 30 questions distributed in three scales (emotion charts, symptom scales, social and physical functioning charts) to assess the psychological impact of psoriasis on the patient quality of life. Group 1 consisted of 70 patients, mean age 47.14 (SD ±15.41) years, 36 (51.43%) male and 34 (48.57%) female. The mean duration of psoriasis was 15.52 (SD ±12.54) years. Group 2 consisted of 50 psoriasis patients without comorbidity, mean age 47.28 (SD ±14.37), 26 (52%) male and 24 (48%) female. The mean duration of psoriasis was 36 months. The PASI value was 16.65 in group 1 and 7.59 in group 2 (t=6.19; p<0.0001). The Skindex-29 values (mean ± SD) were as follows in group 1 and group 2: symptom scale 19.04±4.36 vs. 16.28±5.73; emotion scale 22.82±6.53 vs. 28.40±8.62; scale of social and physical functioning 28.11±8,88 vs. 26.64±9.90; and total score 24.64±5.88 vs. 23.77±7.18 (t=0.73, p=0.46). There was no correlation between PASI and quality of life in the study sample (r=0.08, p=0.36). In conclusion, psoriasis affects the quality of life in patients with this condition regardless of the severity of clinical features and presence of comorbidity.
Ključne riječi
psoriasis; quality of life; comorbidity; PASI; Skindex-29
Hrčak ID:
193705
URI
Datum izdavanja:
15.2.2018.
Posjeta: 1.807 *